Buscar resultados de ensayos clínicos
Sarcoma, Synovial - 20 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: DHEA in Synovial Sarcoma Patients Condición:
|
Terminated |
Nombre del estudio: First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 Condición: Sarcoma, Synovial Fecha: 2011-11-03 Intervenciones:
|
Terminated |
Nombre del estudio: A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma Condición: Synovial Sarcoma Fecha: 2005-08-30 Intervenciones: Drug: Anti-CTLA4 (monoclonal antibody MDX-010) |
Recruiting |
Nombre del estudio: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Condición: Synovial Sarcoma Fecha: 2011-04-26 Intervenciones: Biological: NY-ESO-1(c259)T Cells Cytoreductive chemotherapy followed by infusion with NY-ESO-1(c259) tr |
Recruiting |
Nombre del estudio: Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases Condición:
Fecha: 2014-07-02 Intervenciones: Radiation: Whole Lung IMRT External beam radiation therapy will be administered on an outpatient basis, |
Not yet recruiting |
Nombre del estudio: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma Condición:
|
Completed |
Nombre del estudio: Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Condición: Sarcoma Fecha: 2005-03-03 Intervenciones: Biological: trastuzumab |
Completed |
Nombre del estudio: Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Condición: Sarcoma Fecha: 2003-01-24 Intervenciones: Drug: gefitinib |
Withdrawn |
Nombre del estudio: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma Condición:
|